<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetes</journal-id><journal-id journal-id-type="publisher-id">diabetes</journal-id><journal-title>Diabetes</journal-title><issn pub-type="ppub">0012-1797</issn><issn pub-type="epub">1939-327X</issn><publisher><publisher-name>American Diabetes Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57102652</article-id><article-id pub-id-type="doi">10.2337/db08-0495</article-id><article-id pub-id-type="pmid">18633104</article-id><article-categories><subj-group subj-group-type="heading"><subject>Obesity Studies</subject></subj-group></article-categories><title-group><article-title>Impaired Glucose Tolerance and Insulin Resistance Are Associated With Increased Adipose 11&#x003b2;-Hydroxysteroid Dehydrogenase Type 1 Expression and Elevated Hepatic 5&#x003b1;-Reductase Activity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tomlinson</surname><given-names>Jeremy W.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Finney</surname><given-names>Joanne</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Gay</surname><given-names>Christopher</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hughes</surname><given-names>Beverly A.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hughes</surname><given-names>Susan V.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Stewart</surname><given-names>Paul M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Division of Medical Sciences, Institute of Biomedical Research, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, U.K</aff><aff id="aff2"><label>2</label>Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, U.K</aff><author-notes><fn><p>Corresponding author: Jeremy W. Tomlinson, <email>j.w.tomlinson&#x00040;bham.ac.uk</email></p></fn></author-notes><pub-date pub-type="ppub"><month>10</month><year>2008</year></pub-date><volume>57</volume><issue>10</issue><fpage>2652</fpage><lpage>2660</lpage><history><date date-type="received"><day>11</day><month>4</month><year>2008</year></date><date date-type="accepted"><day>30</day><month>6</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008, American Diabetes Association</copyright-statement><license license-type="open-access"><p>Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link> for details.</p></license></permissions><self-uri xlink:title="pdf" xlink:href="zdb01008002652.pdf"/><abstract><p><bold>OBJECTIVE&#x02014;</bold>The precise molecular mechanisms contributing to the development of insulin resistance, impaired glucose tolerance (IGT), and type 2 diabetes are largely unknown. Altered endogenous glucocorticoid metabolism, including 11&#x003b2;-hydroxysteroid dehydrogenase type 1 (11&#x003b2;-HSD1), which generates active cortisol from cortisone, and 5&#x003b1;-reductase (5&#x003b1;R), which inactivates cortisol, has been implicated.</p><p><bold>RESEARCH DESIGN AND METHODS&#x02014;</bold>A total of 101 obese patients (mean age 48 &#x000b1; 7 years, BMI 34.4 &#x000b1; 4.3 kg/m<sup>2</sup>, 66 women, 35 men) underwent 75-g oral glucose tolerance testing (OGTT), body composition analysis (dual-energy X-ray absorptiometry), assessment of glucocorticoid metabolism (24-h urine steroid metabolite analysis by gas chromatography/mass spectrometry), and subcutaneous abdominal adipose tissue biopsies.</p><p><bold>RESULTS&#x02014;</bold>A total of 22.7&#x00025; of women had IGT compared with 34.2&#x00025; of men. Two women and five men were diagnosed with type 2 diabetes. In women, adipose 11&#x003b2;-HSD1 expression was increased in patients with IGT and correlated with glucose levels across the OGTT (<italic>R</italic> &#x0003d; 0.44, <italic>P</italic> &#x0003c; 0.001) but was independent of fat mass. Total glucocorticoid secretion was higher in men with and without IGT (normal 13,743 &#x000b1; 863 vs. 7,453 &#x000b1; 469 &#x003bc;g/24 h, <italic>P</italic> &#x0003c; 0.001; IGT 16,871 &#x000b1; 2,113 vs. 10,133 &#x000b1; 1,488 &#x003bc;g/24 h, <italic>P</italic> &#x0003c; 0.05), and in women, it was higher in those with IGT (7,453 &#x000b1; 469 vs. 10,133 &#x000b1; 1,488 &#x003bc;g/24 h, <italic>P</italic> &#x0003c; 0.001). In both sexes, 5&#x003b1;R activity correlated with fasting insulin (men <italic>R</italic> &#x0003d; 0.53, <italic>P</italic> &#x0003d; 0.003; women <italic>R</italic> &#x0003d; 0.33, <italic>P</italic> &#x0003d; 0.02), insulin secretion across an OGTT (men <italic>R</italic> &#x0003d; 0.46, <italic>P</italic> &#x0003d; 0.01; women <italic>R</italic> &#x0003d; 0.40, <italic>P</italic> &#x0003d; 0.004), and homeostasis model assessment of insulin resistance (men <italic>R</italic> &#x0003d; 0.52, <italic>P</italic> &#x0003d; 0.004; women <italic>R</italic> &#x0003d; 0.33, <italic>P</italic> &#x0003d; 0.02).</p><p><bold>CONCLUSIONS&#x02014;</bold>Increased adipose 11&#x003b2;-HSD1 expression in women may contribute to glucose intolerance. Enhanced 5&#x003b1;R activity in both sexes is associated with insulin resistance but not body composition. Augmented glucocorticoid inactivation may serve as a compensatory, protective mechanism to preserve insulin sensitivity.</p></abstract></article-meta><notes><fn-group><fn><p>Published ahead of print at <ext-link ext-link-type="uri" xlink:href="http://diabetes.diabetesjournals.org">http://diabetes.diabetesjournals.org</ext-link> on 15 June 2008.</p><p>The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked &#x0201c;advertisement&#x0201d; in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.</p></fn></fn-group></notes></front><body><p>Despite the severe health consequences of obesity (<xref ref-type="bibr" rid="r1">1</xref>) and the alarming rate at which its prevalence is increasing (<xref ref-type="bibr" rid="r2">2</xref>), many questions remain unanswered with regard to its pathogenesis and etiology. Insulin resistance and obesity are tightly associated, yet the molecular mechanisms that underpin this relationship are unknown. Insulin resistance has been implicated as central not only to the development of obesity itself but also its complications, including dyslipidemia, thromboembolic disease, and hypertension (<xref ref-type="bibr" rid="r3">3</xref>). Furthermore, it is a feature of many other clinical conditions, including polycystic ovary syndrome (PCOS), where the degree of insulin resistance exceeds that observed in body composition&#x02013;matched control subjects (<xref ref-type="bibr" rid="r4">4</xref>). The association between insulin resistance and obesity almost certainly explains the dramatic relationship between obesity and type 2 diabetes (<xref ref-type="bibr" rid="r5">5</xref>,<xref ref-type="bibr" rid="r6">6</xref>). Type 2 diabetes evolves from a state of insulin resistance with hyperinsulinema necessary to maintain glucose tolerance. Type 2 diabetes is manifest when insulin secretion fails to meet demands, with consequent hyperglycemia and eventual pancreatic &#x003b2;-cell failure. Impaired glucose tolerance (IGT), defined as a 2-h glucose concentration &#x0003e;7.8 mmol/l but &#x0003c;11.1 mmol/l after 75-g oral glucose testing (OGTT), significantly increases the risk of progression to type 2 diabetes (<xref ref-type="bibr" rid="r7">7</xref>), and although rates of progression to type 2 diabetes are variable, they may exceed 10&#x00025; per year (<xref ref-type="bibr" rid="r8">8</xref>,<xref ref-type="bibr" rid="r9">9</xref>). Although the benefits of lifestyle intervention are clear (<xref ref-type="bibr" rid="r9">9</xref>), the molecular mechanisms that cause IGT and, similarly, the mechanisms by which IGT progresses to type 2 diabetes are largely unknown.</p><p>The role of endogenous glucocorticoids in the development of obesity and insulin resistance has been widely speculated on based upon observation in patients with glucocorticoid excess (Cushing's syndrome). These patients develop a classical phenotype including central obesity, insulin resistance, and in some cases type 2 diabetes. However, simple obesity and insulin resistance are not caused by subclinical endogenous glucocorticoid excess; circulating cortisol levels in obese patients are not elevated (<xref ref-type="bibr" rid="r10">10</xref>). Tissue-specific glucocorticoid metabolism, however, may be important. The enzyme 11&#x003b2;-hydroxysteroid dehydrogenase type 1 (11&#x003b2;-HSD1) is highly expressed in liver, adipose tissue, and muscle and generates the active glucocorticoid cortisol from inactive cortisone and therefore amplifies local glucocorticoid action (<xref ref-type="bibr" rid="r11">11</xref>). However, 11&#x003b2;-HSD1 is a bidirectional enzyme and is capable of inactivating cortisol to cortisone. Critically, the directionality of 11&#x003b2;-HSD1 activity is cofactor (NADPH) dependent, which is supplied by a tightly associated endolumenal enzyme, hexose-6-phopshate dehydrogenase (H6PDH). Decreases in H6PDH expression and activity decrease oxoreductase and increase dehydrogenase activity (<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r13">13</xref>). Recently, much attention has focused on pharmacological manipulation of cortisol metabolism as a therapeutic strategy. Selective 11&#x003b2;-HSD1 inhibitors administered to rodents and primates decrease local glucocorticoid generation, improve glucose tolerance, increase insulin sensitivity, and may promote weight loss (<xref ref-type="bibr" rid="r14">14</xref>&#x02013;<xref ref-type="bibr" rid="r17">17</xref>). In contrast to the action of 11&#x003b2;-HSD1, the A-ring reductases (5&#x003b1;-reductase type 1 &#x0005b;5&#x003b1;R1&#x0005d; and type 2 &#x0005b;5&#x003b1;R2&#x0005d; and 5&#x003b2;-reductase) inactivate cortisol, decreasing local glucocorticoid availability to bind and activate the glucocorticoid receptor (GR). 5&#x003b1;R1 is expressed in skin and adipose tissue (<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r19">19</xref>) and 5&#x003b1;R2 in prostate, epididymis, and seminal vesicles; both isozymes are expressed in the liver (<xref ref-type="bibr" rid="r18">18</xref>).</p><p>Studies published to date have focused principally on the role of cortisol metabolism in the pathogenesis of obesity rather than that of insulin resistance. We have performed a detailed clinical study in a large cohort of obese patients exploring the concept that cortisol metabolism is an important regulator of insulin sensitivity and that this may be independent of fat mass. We have hypothesized that decreased local glucocorticoid availability (through decreased 11&#x003b2;-HSD1 and/or increased A-ring reductase activity) will represent a novel physiological adaptive response to preserve insulin sensitivity in a cohort of patients predisposed to the development of insulin resistance, IGT, and type 2 diabetes.</p><sec><title>RESEARCH DESIGN AND METHODS</title><p>The study was approved by the South Birmingham Local Research Ethics Committee, and all subjects gave informed, written consent. A total of 101 obese volunteers (35 male, 66 female, mean age &#x000b1; SD 48 &#x000b1; 7 years, mean BMI 34.4 &#x000b1; 4.3 kg/m<sup>2</sup>) were recruited following local advertisement and underwent the clinical protocol described below. Patients had no significant past medical history, and none had received glucocorticoid therapy (oral, topical, or inhaled) within the last 12 months. All patients had normal blood counts and renal function.</p><p>Subjects were investigated in the fasting state. Blood samples were drawn at 9 <sc>a.m.</sc> for measurement of total cholesterol, triglycerides, cortisol, cortisone, glucose, insulin, and A1C. Measurements of BMI, waist circumference (measured supine, at the level of the umbilicus), hip circumference (at the level of the greater trochanter), and blood pressure (average of three readings, measured supine after 10 min rest using Dynamap &#x0005b;Critikon, Tampa, FL&#x0005d;) were also taken. Patients underwent a standard 75-g oral glucose tolerance test, with samples taken at 30-min intervals for 120 min for measurement of insulin and glucose.</p><p>In the fasting state, all patients had an abdominal subcutaneous adipose tissue biopsy (10&#x02013;15 cm lateral to the umbilicus) performed under local anesthetic (1&#x02013;2 ml of 1&#x00025; lidocaine) in order to obtain &#x0223c;250&#x02013;500 mg of adipose tissue. The sample was immediately placed in RNALater (Ambion, Austin, TX) and, after initial storage for 24 h at room temperature, was stored at &#x02212;20&#x000b0;C for subsequent total RNA extraction, reverse transcription, and real-time PCR analysis.</p><p>In addition, all patients performed a 24-h urine collection for corticosteroid metabolite analysis (<xref ref-type="bibr" rid="r20">20</xref>). Body composition analysis was performed using dual-energy X-ray absorptiometry (DEXA) with a total body scanner (QDR 45OO; Hologic, Bedford, MA). Coefficients of variation (CVs) for multiple scans were &#x0003c;3&#x00025;. Regional fat mass (trunk and leg) was analyzed as previously described (<xref ref-type="bibr" rid="r21">21</xref>).</p><sec><title>Biochemical assays.</title><p>Blood counts, urea, creatinine and electrolytes, cholesterol, triglycerides, liver chemistry, glucose, and A1C were measured using standard laboratory methods (Roche Modular system; Roche, Lewes, U.K.). Insulin was measured using a commercially available colorimetric ELISA (Mercodia, Uppsala, Sweden) with an in-house CV of &#x0003c;5&#x00025;. Cortisol was measured using a coat-a-count radioimmunoassay (Diagnostic Products, Los Angeles, CA) as per the manufacturer's guidelines. Cortisone was assayed after extraction from serum followed by radioimmunoassay of the extract with <sup>125</sup>I-cortisone and Sac-Cel (IDS, Tyne and Weir, U.K.) second antibody separation (<xref ref-type="bibr" rid="r22">22</xref>). The CV for 10 consecutive assays was &#x0003c;15&#x00025; for values between 50 and 100 nmol/l and &#x0003c;10&#x00025; for values over 100 nmol/l.</p><p>Calculated measures of pancreatic &#x003b2;-cell function and insulin resistance were made using the homeostasis model assessment (HOMA) 2 model (<xref ref-type="bibr" rid="r23">23</xref>). The HOMA of &#x003b2;-cell function (HOMA &#x00025;B) values provide an index of pancreatic islet &#x003b2;-cell function relative to a normal individual with a value set at 100&#x00025;. Similarly, HOMA of insulin sensitivity (HOMA &#x00025;S) values represent a measure of insulin sensitivity relative to a normal individual, again with a value of 100&#x00025;. The HOMA of insulin resistance is a reciprocal measure of the &#x00025;S values.</p></sec><sec><title>Urinary corticosteroid metabolites.</title><p>Urinary corticosteroid metabolite analysis was performed by gas chromatography/mass spectrometry (GC/MS) as described previously (<xref ref-type="bibr" rid="r20">20</xref>). The sum of total cortisol metabolites (tetrahydrocortisol &#x0005b;THF&#x0005d;, tetrahydrocortisone &#x0005b;THE&#x0005d;, 5&#x003b1;-THF, &#x003b1;-cortolone, cortisone &#x0005b;E&#x0005d;, cortisol &#x0005b;F&#x0005d;, &#x003b2;-cortolone, &#x003b2;-cortol, and &#x003b1;-cortol) provides a reflection of cortisol secretion rate. The ratio of tetrahydrometabolites of cortisol (THF &#x0002b; 5&#x003b1;THF) to those of cortisone (THE) provides a reflection of 11&#x003b2;-HSD1 activity when considered with the ratio of urinary free cortisol to cortisone, which more accurately reflects renal 11&#x003b2;-HSD2 activity (<xref ref-type="bibr" rid="r20">20</xref>). The ratios of cortols to cortolones and of 11&#x003b2;-hydroxy-etiocholanolone and 11&#x003b2;-hydroxy-androsterone combined to 11oxo-etiocholanolone also reflect 11&#x003b2;-HSD1 activity (<xref ref-type="bibr" rid="r24">24</xref>). The activities of 5&#x003b1;- and 5&#x003b2;-reductases can be inferred from measuring the ratio of 5&#x003b1; THF to THF and androsterone to etiocholanolone.</p></sec><sec><title>RNA extraction and reverse transcription.</title><p>Following subcutaneous adipose tissue biopsy, total RNA was extracted using a single-step extraction method (Magmax 96; Applied Biosystems, Foster City, CA) as per the manufacturer's guidelines. RNA integrity and quantity were assessed using a Nanodrop spectrophotometer (Wilmington, DE).</p><p>One microgram of total RNA was initially denatured by heating to 70&#x000b0;C for 5 min. Thirty units of avian myeloblastososis virus, 200 ng of random primers, 20 units of ribonuclease inhibitor, and 40 nmol of deoxy&#x02013;nucleoside triphosphates with 5&#x000d7; reaction buffer were added to the RNA, and the reverse transcriptase reaction was carried out at 37&#x000b0;C for 1 h. The reaction was terminated by heating the cDNA to 95&#x000b0;C for 5 min.</p></sec><sec><title>Real-time PCR.</title><p>mRNA levels of genes of interest were determined using an ABI 7500 sequence detection system (Perkin-Elmer and Applied Biosystems, Warrington, U.K.). Reactions were performed in 25-&#x003bc;l volumes on 96-well plates in reaction buffer containing 2&#x000d7; TaqMan Universal PCR Master mix (Applied Biosystems, Foster City, CA). Probes and primers for all genes were supplied by assay on demand (Applied Biosystems). All reactions were normalized against the housekeeping gene 18S rRNA, provided as a preoptimized control probe.</p><p>Data were measured as the cycle number at which logarithmic PCR plots cross a calculated threshold line (CT) and used to determine &#x00394;CT values &#x0005b;(&#x00394;CT of the target gene) &#x02212; (&#x00394;CT of the housekeeping gene). Data were expressed as arbitrary units (AU) using the following transformation: expression &#x0003d; 10<sup>5</sup>&#x000d7; (2<sup>&#x02212;&#x00394;CT</sup>) AU.</p></sec><sec><title>Statistical analysis.</title><p>Data are presented as means &#x000b1; SE unless otherwise stated. Area under the curve (AUC) analysis was performed using the trapezoidal method. For comparison of single variables, <italic>t</italic> tests have been used (or nonparametric equivalents where data were not normally distributed). Regression analyses were performed using Pearson correlations; where more than one variable was considered, multiple linear regression analysis was used. All analysis was performed using SigmaStat 3.1 (Systat Software, Point Richmond, CA).</p></sec></sec><sec><title>RESULTS</title><p>A total of 101 (66 women and 35 men) volunteers were recruited into the study; 48 women (72.7&#x00025;) and 17 men (48.6&#x00025;) had normal fasting glucose levels and normal glucose tolerance. Two women (3.0&#x00025;) and three men (8.6&#x00025;) had impaired fasting glucose (IFG) (&#x0003e;5.6 mmol/l), and within this group, two men and no women had IGT. IGT with normal fasting glucose concentrations was observed in 15 women (22.7&#x00025;) and 10 men (28.6&#x00025;). Type 2 diabetes was diagnosed in two women (3.0&#x00025;) and five men (14.3&#x00025;), and all subjects with type 2 diabetes had IFG. Taking into account the sexual dimorphism described in body composition and glucocorticoid metabolite production rates, subsequent analysis was performed separately in men and women.</p><sec><title>Normal glucose tolerance versus IGT and IFG.</title><p>IGT was associated with increased waist circumference (103 &#x000b1; 1.3 vs. 111 &#x000b1; 2 cm, <italic>P</italic> &#x0003c; 0.002) and waist-to-hip ratio (WHR) (0.87 &#x000b1; 0.01 vs. 0.90 &#x000b1; 0.01, <italic>P</italic> &#x0003c; 0.05) in women but not in men (waist circumference 114 &#x000b1; 3 vs. 116 &#x000b1; 3 cm, <italic>P</italic> &#x0003d; 0.57; WHR 0.98 &#x000b1; 0.02 vs. 0.99 &#x000b1; 0.01, <italic>P</italic> &#x0003d; 0.46).</p><p>A1C was increased in both men and women with IGT, although this only reached statistical significance in men (men 5.3 &#x000b1; 0.1 vs. 5.9 &#x000b1; 0.3&#x00025;, <italic>P</italic> &#x0003c; 0.05; women 5.4 &#x000b1; 0.1 vs. 5.7 &#x000b1; 0.1&#x00025;, <italic>P</italic> &#x0003d; 0.08). Surprisingly, measures of insulin resistance (HOMA-R, fasting and 2-h insulin concentrations) were not different between groups (<xref ref-type="table" rid="t1">Table 1</xref>). Furthermore, body composition analysis by DEXA failed to show differences in fat-free mass or total or regional fat mass between those patients with normal glucose tolerance or IGT (<xref ref-type="table" rid="t1">Table 1</xref>). Although men and women were not different in terms of insulin resistance (as measured by HOMA, fasting insulin, 2-h insulin or insulin AUC across the 75-g OGTT, percent trunk fat and absolute total and trunk fat mass were higher in women with correspondingly lower fat-free masses (<xref ref-type="table" rid="t1">Table 1</xref>).</p><p>Urinary steroid metabolite analysis by GC/MS demonstrated clear sexual dimorphism with increased total and individual glucocorticoid metabolite production rates in men compared with women for subjects with and without IGT (<xref ref-type="table" rid="t2">Table 2</xref>). When analyzed according to glucose tolerance, total glucocorticoid production rates were higher in women with IGT compared with women with normal glucose tolerance (10,133 &#x000b1; 1,488 vs. 7,453 &#x000b1; 469, respectively, <italic>P</italic> &#x0003c; 0.05), but this relationship was not observed in men (16,871 &#x000b1; 2,113 vs. 13,743 &#x000b1; 863, respectively, <italic>P</italic> &#x0003d; 0.17). Furthermore, there were no differences in absolute production rates for individual metabolites or activities of metabolizing enzymes (in particular 11&#x003b2;-HSD1 or 5&#x003b1;R) when comparing normal and IGT subjects (<xref ref-type="table" rid="t2">Table 2</xref>).</p></sec><sec><title>Adipose tissue biopsy gene expression.</title><p>Successful isolation of total RNA and generation of cDNA from subcutaneous adipose tissue biopsies was achieved in 90 volunteers. All samples expressed 11&#x003b2;-HSD1, H6PDH, GR, and 5&#x003b1;R1. In contrast, 5&#x003b1;R2 was only expressed in 5 of 90 samples and only at very low levels (data not shown).</p><p>Whereas 11&#x003b2;-HSD1, GR, and 5&#x003b1;R1 mRNA expression levels were similar in men and women, H6PDH expression was higher in biopsies from male volunteers (2.3 &#x000b1; 0.4 vs. 1.6 &#x000b1; 0.5 AU, <italic>P</italic> &#x0003c; 0.05).</p><p>In women only, adipose tissue 11&#x003b2;-HSD1 expression was higher in those with IGT than in those with normal glucose tolerance (0.5 &#x000b1; 0.06 vs. 0.29 &#x000b1; 0.03 AU, <italic>P</italic> &#x0003c; 0.005), despite fat mass (total and regional) being similar between the two groups (<xref rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>). Moreover, expression correlated with glucose AUC across the OGTT (<italic>R</italic> &#x0003d; 0.44, <italic>P</italic> &#x0003c; 0.005) (<xref rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>) but not with fat mass (total fat mass <italic>R</italic> &#x0003d; 0.12, <italic>P</italic> &#x0003d; NS; trunk fat mass <italic>R</italic> &#x0003d; 0.15, <italic>P</italic> &#x0003d; NS). H6PDH expression was lower in female volunteers with IGT (0.79 &#x000b1; 0.1 vs. 1.38 &#x000b1; 0.14 AU, <italic>P</italic> &#x0003c; 0.05), but GR and 5&#x003b1;R1 expression did not differ (<xref rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>). In contrast to our findings in women, expression of 11&#x003b2;-HSD1, H6PDH, GR, and 5&#x003b1;R1 in adipose tissue biopsies from men did not differ between those with and those without IGT and did not relate to glucose levels across an OGTT (<xref rid="f1" ref-type="fig">Fig. 1<italic>C</italic> and <italic>D</italic></xref>).</p></sec><sec><title>Regression analyses.</title><p>Univariate regression analysis revealed positive relationships between 5&#x003b1;R activity (as measured by both the urinary androsterone&#x02013;to&#x02013;etiocholanolone and 5&#x003b1;THF-to-THF ratios) and markers of insulin resistance. In women, significant correlations were observed with fasting insulin, 2-h insulin levels after 75 g oral glucose, AUC insulin across the OGTT, and HOMA-R (<xref ref-type="table" rid="t3">Table 3</xref> and <xref rid="f2" ref-type="fig">Fig. 2<italic>A</italic>&#x02013;<italic>D</italic></xref>). In men, a similar pattern was observed (<xref ref-type="table" rid="t3">Table 3</xref>; <xref rid="f2" ref-type="fig">Fig. 2<italic>A</italic>&#x02013;<italic>D</italic></xref>), but in addition, increased 5&#x003b1;R activity was associated with decreased pancreatic &#x003b2;-cell function as calculated from the HOMA-&#x00025;B (<xref ref-type="table" rid="t3">Table 3</xref>).</p><p>Activity of 5&#x003b1;R increased with increasing total and regional fat and fat-free mass in men but not in women (<xref ref-type="table" rid="t3">Table 3</xref>). While these relationships remained significant, they were weaker than those observed with markers of insulin resistance. There was no relationship in either sex with fat distribution as measured by waist circumference, WHR, or the trunk fat&#x02013;to&#x02013;limb fat ratio via DEXA.</p><p>Total glucocorticoid secretion rate increased with total and regional fat and fat-free mass in women but not in men and was weakly associated with 2-h insulin concentration after 75 g oral glucose (<xref ref-type="table" rid="t4">Table 4</xref>). Global 11&#x003b2;-HSD1 activity as measured by the 5&#x003b1; THF &#x0002b; THF&#x02013;to&#x02013;THE ratio was unrelated to metabolic or anthropometric variables in women and only weakly related to HOMA-R in men (<italic>R</italic> &#x0003d; 0.38, <italic>P</italic> &#x0003d; 0.04). 11&#x003b2;-HSD2 inactivates cortisol to cortisone in mineralocorticoid target tissues, notably the kidney. Activity is reflected in the ratio of urinary free cortisol to cortisone. This was unrelated to metabolic parameters with the exception of 2-h insulin levels in men only (<italic>R</italic> &#x0003d; 0.389, <italic>P</italic> &#x0003d; 0.03) and inversely related to WHR in women only (<italic>R</italic> &#x0003d; &#x02212;0.30, <italic>P</italic> &#x0003d; 0.04).</p><p>Using multivariate modeling to correct for total and regional fat mass, 5&#x003b1;R activity remained an independent predictor of insulin secretion across the OGTT (2-h insulin <italic>P</italic> &#x0003c; 0.005; insulin AUC <italic>P</italic> &#x0003c; 0.005) in women. In men, 5&#x003b1;R activity and not fat mass independently predicted fasting insulin levels (<italic>P</italic> &#x0003c; 0.05), HOMA-&#x00025;B (<italic>P</italic> &#x0003c; 0.05), HOMA-&#x00025;S (<italic>P</italic> &#x0003c; 0.05), and HOMA-R (<italic>P</italic> &#x0003c; 0.05).</p></sec></sec><sec><title>DISCUSSION</title><p>In this unselected cohort of obese patients, we have identified the prevalence of IGT to be 22.7&#x00025; in women and 34.2&#x00025; in men and the prevalence of type 2 diabetes to be 3.0&#x00025; in women and 14.3&#x00025; in men. This was associated with central fat distribution (but not absolute fat mass) in women and unrelated to fat mass or distribution in men.</p><p>In this cohort, subcutaneous adipose tissue 11&#x003b2;-HSD1 mRNA expression was higher in women with IGT and correlated with glucose secretion across the OGTT but was unrelated to fat mass, consistent with our previous observations (<xref ref-type="bibr" rid="r25">25</xref>). Previous studies have examined 11&#x003b2;-HSD1 mRNA expression and activity in adipose tissue in the context of fat mass with variable results. Within the subcutaneous depot, most studies, although not all, have suggested increased expression with indexes of obesity (<xref ref-type="bibr" rid="r25">25</xref>&#x02013;<xref ref-type="bibr" rid="r29">29</xref>), but relative expression within the intra-abdominal depot remains controversial. Importantly, the expression of 11&#x003b2;-HSD1 in adipose tissue and its relationship with insulin resistance and glucose tolerance has not been examined before. While expression studies were only performed in subcutaneous adipose tissue, enhanced cortisol generation through increased 11&#x003b2;-HSD1 mRNA expression may contribute to glucose intolerance through increased lipolysis (<xref ref-type="bibr" rid="r30">30</xref>,<xref ref-type="bibr" rid="r31">31</xref>) and generation of free fatty acids, which impair peripheral glucose uptake (<xref ref-type="bibr" rid="r32">32</xref>). However, due to the small volumes of tissue obtained, activity studies were not performed and it is possible that decreased H6PDH expression that we also observed in the IGT group may decrease 11&#x003b2;-HSD1 oxo-reductase activity by limiting cofactor supply.</p><p>Sexually dimorphic activity and expression of 11&#x003b2;-HSD1 has been described in some studies (<xref ref-type="bibr" rid="r33">33</xref>) but not all (<xref ref-type="bibr" rid="r34">34</xref>). In our cohort, urinary GC/MS analysis was similar in men and women. Studies examining sex-specific regulation of expression within adipose tissue are lacking. In nonadipose tissue, estradiol has been shown to regulate expression levels, and it is possible that this may contribute to our observations; however, the published data are often contradictory with studies showing both increased and decreased expression (<xref ref-type="bibr" rid="r35">35</xref>&#x02013;<xref ref-type="bibr" rid="r38">38</xref>). With the exception of dehydroepiandrosterone (<xref ref-type="bibr" rid="r39">39</xref>), there is little evidence to support a role for regulation by androgens (<xref ref-type="bibr" rid="r35">35</xref>,<xref ref-type="bibr" rid="r38">38</xref>). Sexually dimorphic expression of H6PDH has not been described previously, and the observed increase in expression in men will need to be endorsed with dedicated activity studies to see if changes in H6PDH expression translate into alterations in glucocorticoid availability. However, it is possible that this could contribute to differences in fat distribution between men and women, with the consequent increase in cardiovascular risk (<xref ref-type="bibr" rid="r40">40</xref>).</p><p>In our study, in both sexes, 5&#x003b1;R activity as measured by urinary glucocorticoid metabolite ratios increased with indexes of insulin resistance, an observation that was independent of fat mass. The role of 5&#x003b1;R in the control of body composition and insulin sensitivity has not been explored in detail in the published literature. The global measures of activity that we have used in this study do not allow us to distinguish between 5&#x003b1;R1 and 5&#x003b1;R2, and whereas patients with 5&#x003b1;R2 mutations have clear evidence of abnormal hepatic cortisol metabolism (<xref ref-type="bibr" rid="r41">41</xref>), the contribution of 5&#x003b1;R1 is yet to be clarified. Sexual dimorphism of 5&#x003b1;R activity has been described with increased activity in male subjects (<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r34">34</xref>). In our study, absolute levels of 5&#x003b1;- and 5&#x003b2;-reduced metabolites were higher in men (as was total glucocorticoid production rate), but the relative balance of 5&#x003b1;R and 5&#x003b2;R activity was not different. Furthermore, 5&#x003b1;R1 mRNA expression in subcutaneous adipose tissue was similar in men and women. Studies in small cohorts of patients have shown enhanced 5&#x003b1;R activity with obesity (<xref ref-type="bibr" rid="r42">42</xref>) and type 2 diabetes (<xref ref-type="bibr" rid="r43">43</xref>) and regulation of 5&#x003b1;R and 5&#x003b2;R activity by dietary macronutrient composition; high-fat, low-carbohydrate and moderate-fat, moderate-carbohydrate diets decrease 5&#x003b1;R and 5&#x003b2;R activity in the context of weight loss (<xref ref-type="bibr" rid="r44">44</xref>). Thiazolidinedione treatment of obese Z&#x000fc;cker rats decreases 5&#x003b1;R1 expression in the liver (<xref ref-type="bibr" rid="r45">45</xref>), but similar experiments in humans have not been performed. However, we have recently shown that following weight loss with consequent insulin sensitization, 5&#x003b1;R activity decreased (<xref ref-type="bibr" rid="r46">46</xref>). 5&#x003b1;R has been implicated in the pathogenesis of the insulin resistance associated with PCOS, in that patients with PCOS are more insulin resistant compared with body composition&#x02013;matched control subjects (<xref ref-type="bibr" rid="r4">4</xref>) and have increased 5&#x003b1;R activity (<xref ref-type="bibr" rid="r47">47</xref>). Moreover, within a cohort of patients with PCOS, 5&#x003b1;R activity correlates with insulin resistance (<xref ref-type="bibr" rid="r48">48</xref>). Our findings are consistent with these data and extend this observation to healthy obese women and men, as well as demonstrate that the relationship (in both sexes) is independent of fat mass. In the context of insulin resistance, we postulate that increased 5&#x003b1;R activity represents a compensatory mechanism to decrease local glucocorticoid availability and occurs in conjunction with the decrease in 11&#x003b2;-HSD1 activity (as evidenced by reduced cortisol generation following oral cortisone administration and decreased urinary 5&#x003b1;- &#x0002b; THF&#x02013;to&#x02013;THE ratios) that we and others have previously described in obesity (<xref ref-type="bibr" rid="r22">22</xref>,<xref ref-type="bibr" rid="r26">26</xref>). These processes act together (decreased generation of cortisol through a reduction in 11&#x003b2;-HSD1 and increased inactivation of cortisol through enhanced 5&#x003b1;R activity) to decrease local glucocorticoid availability and decrease GR activation specifically within the liver, with the aim of maintenance of hepatic insulin sensitivity. A further impact of these changes will be to drive the hypothalamo-pituitary-adrenal axis in order to maintain circulating cortisol levels. While we believe that the changes that we have observed largely reflect hepatic glucocorticoid metabolism, a direct effect upon insulin secretion cannot be excluded. However, this remains highly speculative, bearing in mind that evidence of A-ring reductase expression in human pancreatic islets is lacking.</p><p>Pharmacological manipulation of glucocorticoid availability through prereceptor metabolism adds credence to our observations. Selective 11&#x003b2;-HSD1 inhibitors that decrease local glucocorticoid availability remain an exciting therapeutic prospect. Significant improvements in insulin sensitivity, glucose tolerance, and lipid profiles following short-term administration in rodents and primates have been observed. Human clinical studies are still eagerly awaited. Conversely, Finasteride (5&#x003b1;R2 inhibitor) and Dutasteride (combined 5&#x003b1;R1 and 5&#x003b1;R2 inhibitor) are widely used in the treatment of prostatic hypertrophy (<xref ref-type="bibr" rid="r49">49</xref>) based upon their action upon androgen metabolism. However, by decreasing glucocorticoid inactivation, they may have a detrimental impact upon insulin sensitivity, but the studies to address this question have not been performed.</p><p>In conclusion, this study adds to the growing body of evidence that supports a role for 5&#x003b1;R in the control of insulin sensitivity in simple obesity. While little is currently known about the regulation of 5&#x003b1;R activity, limiting local glucocorticoid availability through enhanced 5&#x003b1;R and/or inhibition of 11&#x003b2;-HSD1 activity may have significant clinical benefits. Finally, prospective studies examining the changes in activity and expression of these enzymes over time may begin to shed light on their potential role in the development of IGT and type 2 diabetes.</p></sec></body><back><ack><p>This study was funded by the Wellcome Trust (program grant to P.M.S., ref. 066357/Z/01/Z, and clinician scientist fellowship to J.W.T., ref. 075322/Z/04/Z) and the Medical Research Council (experimental medicine initiative, ref. G0502165).</p><p>We thank all the nursing staff on the Wellcome Trust Clinical Research facility, Queen Elizabeth Hospital, Birmingham where this study took place.</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><citation citation-type="journal">Willett,WC, Dietz,WH, Colditz,GA: Guidelines for healthy weight. <source>N Engl J Med</source><volume>341</volume>:<fpage>427</fpage>&#x02013;434, <year>1999</year><pub-id pub-id-type="pmid">10432328</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="other">World Health Organization web site <ext-link ext-link-type="uri" xlink:href="http://www.who.int/en/">http://www.who.int/en/</ext-link> accessed June <year>2008</year></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal">Lann D, LeRoith D: Insulin resistance as the underlying cause for the metabolic syndrome. <source>Med Clin North Am</source><volume>91</volume>:<fpage>1063</fpage>&#x02013;1077, <year>2007</year><pub-id pub-id-type="pmid">17964909</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal">Legro RS, Kunselman AR, Dodson WC, Dunaif A: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. <source>J Clin Endocrinol Metab</source><volume>84</volume>:<fpage>165</fpage>&#x02013;169, <year>1999</year><pub-id pub-id-type="pmid">9920077</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal">Colditz GA, Willett WC, Rotnitzky A, Manson JE: Weight gain as a risk factor for clinical diabetes mellitus in women. <source>Ann Intern Med</source><volume>122</volume>:<fpage>481</fpage>&#x02013;486, <year>1995</year><pub-id pub-id-type="pmid">7872581</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal">Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC: Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. <source>Diabetes Care</source><volume>17</volume>:<fpage>961</fpage>&#x02013;969, <year>1994</year><pub-id pub-id-type="pmid">7988316</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal">Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L: Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. <source>Diabetes Res Clin Pract</source><volume>78</volume>:<fpage>305</fpage>&#x02013;312, <year>2007</year><pub-id pub-id-type="pmid">17601626</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal">Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. <source>N Engl J Med</source><volume>346</volume>:<fpage>393</fpage>&#x02013;403, <year>2002</year><pub-id pub-id-type="pmid">11832527</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal">Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. <source>N Engl J Med</source><volume>344</volume>:<fpage>1343</fpage>&#x02013;1350, <year>2001</year><pub-id pub-id-type="pmid">11333990</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal">Fraser R, Ingram MC, Anderson NH, Morrison C, Davies E, Connell JM: Cortisol effects on body mass, blood pressure, and cholesterol in the general population. <source>Hypertension</source><volume>33</volume>:<fpage>1364</fpage>&#x02013;1368, <year>1999</year><pub-id pub-id-type="pmid">10373217</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal">Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM: 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. <source>Endocr Rev</source><volume>25</volume>:<fpage>831</fpage>&#x02013;866, <year>2004</year><pub-id pub-id-type="pmid">15466942</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="other">Lavery GG, Walker EA, Draper N, Jeyasuria P, Marcos J, Shackleton CH, Parker KL, White PC, Stewart PM: Hexose-6-phosphate dehydrogenase knockout mice lack 11beta -hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. <source>J Biol Chem.</source><year>2005</year> &#x0005b;Epub ahead of print&#x0005d;</citation></ref><ref id="r13"><label>13</label><citation citation-type="journal">Bujalska IJ, Draper N, Michailidou Z, Tomlinson JW, White PC, Chapman KE, Walker EA, Stewart PM: Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1. <source>J Mol Endocrinol</source><volume>34</volume>:<fpage>675</fpage>&#x02013;684, <year>2005</year><pub-id pub-id-type="pmid">15956339</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal">Alberts P, Engblom L, Edling N, Forsgren M, Klingstrom G, Larsson C, Ronquist-Nii Y, Ohman B, Abrahmsen L: Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. <source>Diabetologia</source><volume>45</volume>:<fpage>1528</fpage>&#x02013;1532, <year>2002</year><pub-id pub-id-type="pmid">12436336</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal">Alberts P, Nilsson C, Selen G, Engblom LO, Edling NH, Norling S, Klingstrom G, Larsson C, Forsgren M, Ashkzari M, Nilsson CE, Fiedler M, Bergqvist E, Eva BB, Abrahmsen LB: Selective inhibition of 11&#x0007b;beta&#x0007d;-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. <source>Endocrinology</source><volume>144</volume>:<fpage>4755</fpage>&#x02013;4762, <year>2003</year><pub-id pub-id-type="pmid">12960099</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal">Berthiaume M, Laplante M, Festuccia W, Gelinas Y, Poulin S, Lalonde J, Joanisse DR, Thieringer R, Deshaies Y: Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11beta-hydroxysteroid dehydrogenase type 1. <source>Endocrinology</source><volume>148</volume>:<fpage>2391</fpage>&#x02013;2397, <year>2007</year><pub-id pub-id-type="pmid">17272400</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal">Bhat BG, Hosea N, Fanjul A, Herrera J, Chapman J, Thalacker F, Stewart PM, Rejto P: Demonstration of Proof of Mechanism and Pharmacokinetics and Pharmacodynamic Relationship with PF-915275, an Inhibitor of 11&#x0007b;beta&#x0007d;HSD1, in Cynomolgus Monkeys. <source>J Pharmacol Exp Ther</source><volume>324</volume>: <fpage>299</fpage>&#x02013;305, <year>2007</year><pub-id pub-id-type="pmid">17921190</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal">Russell DW, Wilson JD: Steroid 5 alpha-reductase: two genes/two enzymes. <source>Annu Rev Biochem</source><volume>63</volume>:<fpage>25</fpage>&#x02013;61, <year>1994</year><pub-id pub-id-type="pmid">7979239</pub-id></citation></ref><ref id="r19"><label>19</label><citation citation-type="journal">Wake DJ, Strand M, Rask E, Westerbacka J, Livingstone DE, Soderberg S, Andrew R, Yki-Jarvinen H, Olsson T, Walker BR: Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. <source>Clin Endocrinol (Oxf)</source><volume>66</volume>:<fpage>440</fpage>&#x02013;446, <year>2007</year><pub-id pub-id-type="pmid">17302881</pub-id></citation></ref><ref id="r20"><label>20</label><citation citation-type="journal">Palermo M, Shackleton CH, Mantero F, Stewart PM: Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. <source>Clin Endocrinol (Oxf)</source><volume>45</volume>:<fpage>605</fpage>&#x02013;611, <year>1996</year><pub-id pub-id-type="pmid">8977758</pub-id></citation></ref><ref id="r21"><label>21</label><citation citation-type="journal">Tomlinson JW, Moore JS, Clark PM, Holder G, Shakespeare L, Stewart PM: Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue. <source>J Clin Endocrinol Metab</source><volume>89</volume>:<fpage>2711</fpage>&#x02013;2716, <year>2004</year><pub-id pub-id-type="pmid">15181046</pub-id></citation></ref><ref id="r22"><label>22</label><citation citation-type="journal">Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH: Cortisol metabolism in human obesity: impaired cortisone&#x02013;&#x0003e;cortisol conversion in subjects with central adiposity. <source>J Clin Endocrinol Metab</source><volume>84</volume>:<fpage>1022</fpage>&#x02013;1027, <year>1999</year><pub-id pub-id-type="pmid">10084590</pub-id></citation></ref><ref id="r23"><label>23</label><citation citation-type="journal">Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. <source>Diabetes Care</source><volume>27</volume>:<fpage>1487</fpage>&#x02013;1495, <year>2004</year><pub-id pub-id-type="pmid">15161807</pub-id></citation></ref><ref id="r24"><label>24</label><citation citation-type="journal">Walker EA, Ahmed A, Lavery GG, Tomlinson JW, Kim SY, Cooper MS, Ride JP, Hughes BA, Shackleton CH, McKiernan P, Elias E, Chou JY, Stewart PM: 11beta-hydroxysteroid dehydrogenase type 1 regulation by intracellular glucose 6-phosphate provides evidence for a novel link between glucose metabolism and hypothalamo-pituitary-adrenal axis function. <source>J Biol Chem</source><volume>282</volume>:<fpage>27030</fpage>&#x02013;27036, <year>2007</year><pub-id pub-id-type="pmid">17588937</pub-id></citation></ref><ref id="r25"><label>25</label><citation citation-type="journal">Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM: Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. <source>J Clin Endocrinol Metab</source><volume>87</volume>:<fpage>5630</fpage>&#x02013;5635, <year>2002</year><pub-id pub-id-type="pmid">12466364</pub-id></citation></ref><ref id="r26"><label>26</label><citation citation-type="journal">Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR: Tissue-specific dysregulation of cortisol metabolism in human obesity. <source>J Clin Endocrinol Metab</source><volume>86</volume>:<fpage>1418</fpage>&#x02013;1421, <year>2001</year><pub-id pub-id-type="pmid">11238541</pub-id></citation></ref><ref id="r27"><label>27</label><citation citation-type="journal">Rask E, Walker BR, Soderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R, Olsson T: Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity. <source>J Clin Endocrinol Metab</source><volume>87</volume>:<fpage>3330</fpage>&#x02013;3336, <year>2002</year><pub-id pub-id-type="pmid">12107245</pub-id></citation></ref><ref id="r28"><label>28</label><citation citation-type="journal">Paulmyer-Lacroix O, Boullu S, Oliver C, Alessi MC, Grino M: Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. <source>J Clin Endocrinol Metab</source><volume>87</volume>:<fpage>2701</fpage>&#x02013;2705, <year>2002</year><pub-id pub-id-type="pmid">12050237</pub-id></citation></ref><ref id="r29"><label>29</label><citation citation-type="journal">Lindsay RS, Wake DJ, Nair S, Bunt J, Livingstone DE, Permana PA, Tataranni PA, Walker BR: Subcutaneous adipose 11beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in pima indians and Caucasians. <source>J Clin Endocrinol Metab</source><volume>88</volume>:<fpage>2738</fpage>&#x02013;2744, <year>2003</year><pub-id pub-id-type="pmid">12788882</pub-id></citation></ref><ref id="r30"><label>30</label><citation citation-type="journal">Slavin BG, Ong JM, Kern PA: Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. <source>J Lipid Res</source><volume>35</volume>:<fpage>1535</fpage>&#x02013;1541, <year>1994</year><pub-id pub-id-type="pmid">7806967</pub-id></citation></ref><ref id="r31"><label>31</label><citation citation-type="other">Tomlinson JW, Sherlock M, Hughes B, Hughes SV, Kilvington F, Bartlett W, Courtney R, Rejto P, Carley W, Stewart PM: Inhibition of 11&#x0007b;beta&#x0007d;-HSD1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis. <source>J Clin Endocrinol Metab</source><year>2007</year></citation></ref><ref id="r32"><label>32</label><citation citation-type="journal">Rigalleau V, Binnert C, Minehira K, Stefanoni N, Schneiter P, Henchoz E, Matzinger O, Cayeux C, Jequier E, Tappy L: In normal men, free fatty acids reduce peripheral but not splanchnic glucose uptake. <source>Diabetes</source><volume>50</volume>:<fpage>727</fpage>&#x02013;732, <year>2001</year><pub-id pub-id-type="pmid">11289035</pub-id></citation></ref><ref id="r33"><label>33</label><citation citation-type="journal">Toogood AA, Taylor NF, Shalet SM, Monson JP: Sexual dimorphism of cortisol metabolism is maintained in elderly subjects and is not oestrogen dependent. <source>Clin Endocrinol (Oxf)</source><volume>52</volume>:<fpage>61</fpage>&#x02013;66, <year>2000</year><pub-id pub-id-type="pmid">10651754</pub-id></citation></ref><ref id="r34"><label>34</label><citation citation-type="journal">Finken MJ, Andrews RC, Andrew R, Walker BR: Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases. <source>J Clin Endocrinol Metab</source><volume>84</volume>:<fpage>3316</fpage>&#x02013;3321, <year>1999</year><pub-id pub-id-type="pmid">10487705</pub-id></citation></ref><ref id="r35"><label>35</label><citation citation-type="journal">Nwe KH, Hamid A, Morat PB, Khalid BA: Differential regulation of the oxidative 11beta-hydroxysteroid dehydrogenase activity in testis and liver. <source>Steroids</source><volume>65</volume>:<fpage>40</fpage>&#x02013;45, <year>2000</year><pub-id pub-id-type="pmid">10624835</pub-id></citation></ref><ref id="r36"><label>36</label><citation citation-type="journal">Ho CK, Tetsuka M, Hillier SG: Regulation of 11beta-hydroxysteroid dehydrogenase isoforms and glucocorticoid receptor gene expression in the rat uterus. <source>J Endocrinol</source><volume>163</volume>:<fpage>425</fpage>&#x02013;431, <year>1999</year><pub-id pub-id-type="pmid">10588816</pub-id></citation></ref><ref id="r37"><label>37</label><citation citation-type="journal">Arcuri F, Battistini S, Hausknecht V, Cintorino M, Lockwood CJ, Schatz F: Human endometrial decidual cell-associated 11 beta-hydroxysteroid dehydrogenase expression: its potential role in implantation. <source>Early Pregnancy</source><volume>3</volume>:<fpage>259</fpage>&#x02013;264, <year>1997</year><pub-id pub-id-type="pmid">10086076</pub-id></citation></ref><ref id="r38"><label>38</label><citation citation-type="journal">Gomez-Sanchez EP, Ganjam V, Chen YJ, Liu Y, Zhou MY, Toroslu C, Romero DG, Hughson MD, de Rodriguez A, Gomez-Sanchez CE: Regulation of 11 beta-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol. <source>Am J Physiol Endocrinol Metab</source><volume>285</volume>:<fpage>E272</fpage>&#x02013;E279, <year>2003</year><pub-id pub-id-type="pmid">12700160</pub-id></citation></ref><ref id="r39"><label>39</label><citation citation-type="journal">Gu S, Ripp SL, Prough RA, Geoghegan TE: Dehydroepiandrosterone affects the expression of multiple genes in rat liver including 11 beta-hydroxysteroid dehydrogenase type 1: a cDNA array analysis. <source>Mol Pharmacol</source><volume>63</volume>:<fpage>722</fpage>&#x02013;731, <year>2003</year><pub-id pub-id-type="pmid">12606783</pub-id></citation></ref><ref id="r40"><label>40</label><citation citation-type="journal">Fontbonne A, Thibult N, Eschwege E, Ducimetiere P: Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: the Paris Prospective Study, 15-year follow-up. <source>Diabetologia</source><volume>35</volume>:<fpage>464</fpage>&#x02013;468, <year>1992</year><pub-id pub-id-type="pmid">1521729</pub-id></citation></ref><ref id="r41"><label>41</label><citation citation-type="journal">Can S, Zhu YS, Cai LQ, Ling Q, Katz MD, Akgun S, Shackleton CH, Imperato-McGinley J: The identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred. <source>J Clin Endocrinol Metab</source><volume>83</volume>:<fpage>560</fpage>&#x02013;569, <year>1998</year><pub-id pub-id-type="pmid">9467575</pub-id></citation></ref><ref id="r42"><label>42</label><citation citation-type="journal">Andrew R, Phillips DI, Walker BR: Obesity and gender influence cortisol secretion and metabolism in man. <source>J Clin Endocrinol Metab</source><volume>83</volume>:<fpage>1806</fpage>&#x02013;1809, <year>1998</year><pub-id pub-id-type="pmid">9589697</pub-id></citation></ref><ref id="r43"><label>43</label><citation citation-type="journal">Andrews RC, Herlihy O, Livingstone DE, Andrew R, Walker BR: Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. <source>J Clin Endocrinol Metab</source><volume>87</volume>:<fpage>5587</fpage>&#x02013;5593, <year>2002</year><pub-id pub-id-type="pmid">12466357</pub-id></citation></ref><ref id="r44"><label>44</label><citation citation-type="journal">Stimson RH, Johnstone AM, Homer NZ, Wake DJ, Morton NM, Andrew R, Lobley GE, Walker BR: Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men. <source>J Clin Endocrinol Metab</source><volume>92</volume>:<fpage>4480</fpage>&#x02013;4484, <year>2007</year><pub-id pub-id-type="pmid">17785367</pub-id></citation></ref><ref id="r45"><label>45</label><citation citation-type="journal">Livingstone DE, McInnes KJ, Walker BR, Andrew R: Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization. <source>Obes Res</source><volume>13</volume>:<fpage>1523</fpage>&#x02013;1526, <year>2005</year><pub-id pub-id-type="pmid">16222053</pub-id></citation></ref><ref id="r46"><label>46</label><citation citation-type="journal">Tomlinson JW, Finney J, Hughes BA, Hughes SV, Stewart PM: Reduced glucocorticoid production rate, decreased 5&#x003b1;-reductase activity and adipose tissue insulin sensitization following weight loss. <source>Diabetes</source><volume>57</volume>:<fpage>1536</fpage>&#x02013;43, <year>2008</year><pub-id pub-id-type="pmid">18340018</pub-id></citation></ref><ref id="r47"><label>47</label><citation citation-type="journal">Stewart PM, Shackleton CHL, Beastall GH, Edwards CRW: 5&#x003b1;-reductase activity in polycystic ovary syndrome. <source>Lancet</source><volume>335</volume>:<fpage>43l</fpage>-433, <year>1990</year></citation></ref><ref id="r48"><label>48</label><citation citation-type="journal">Tsilchorozidou T, Honour JW, Conway GS: Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates. <source>J Clin Endocrinol Metab</source><volume>88</volume>:<fpage>5907</fpage>&#x02013;5913, <year>2003</year><pub-id pub-id-type="pmid">14671189</pub-id></citation></ref><ref id="r49"><label>49</label><citation citation-type="journal">Marberger M: Drug Insight: 5alpha-reductase inhibitors for the treatment of benign prostatic hyperplasia. <source>Nat Clin Pract Urol</source><volume>3</volume>:<fpage>495</fpage>&#x02013;503, <year>2006</year><pub-id pub-id-type="pmid">16964191</pub-id></citation></ref></ref-list></back><floats-wrap><fig position="float" id="f1"><label>FIG. 1.</label><caption><p>In women only, IGT is associated with increased adipose tissue 11&#x003b2;-HSD1 but decreased H6PDH mRNA expression (<italic>A</italic>) without alteration in fat mass; 11&#x003b2;-HSD1 mRNA levels correlate with glucose AUC across an OGTT (<italic>B</italic>). However, in men with IGT, adipose 11&#x003b2;-HSD1, H6PDH, GR, and 5&#x003b1;R1 mRNA expression is not dysregulated (<italic>C</italic> and <italic>D</italic>). &#x025a1;, normal glucose tolerance; &#x025aa;, IGT.</p></caption><graphic xlink:href="zdb0100854700001"></graphic></fig><fig position="float" id="f2"><label>FIG. 2.</label><caption><p>Increasing 5&#x003b1;-reductase activity is associated with increased insulin secretion across an OGTT in men (&#x02022;) and women (&#x025a1;)&#x02014;fasting insulin (<italic>A</italic>), 2-h insulin (<italic>B</italic>), area under curve insulin (<italic>C</italic>), and increased insulin resistance as measured by HOMA-IR (<italic>D</italic>).</p></caption><graphic xlink:href="zdb0100854700002"></graphic></fig><table-wrap position="float" id="t1"><label>TABLE 1</label><caption><p>Clinical and serum biochemical characteristics of obese men and women with normal or IGT</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="3" rowspan="1" align="center" valign="bottom">Women <hr/></th><th colspan="3" rowspan="1" align="center" valign="bottom">Men <hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="1" rowspan="1" align="center" valign="bottom">Normal</th><th colspan="1" rowspan="1" align="center" valign="bottom">IGT</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th><th colspan="1" rowspan="1" align="center" valign="bottom">Normal</th><th colspan="1" rowspan="1" align="center" valign="bottom">IGT</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>n</italic></td><td colspan="1" rowspan="1" align="center" valign="top">48</td><td colspan="1" rowspan="1" align="center" valign="top">15</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top">17</td><td colspan="1" rowspan="1" align="center" valign="top">12</td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Age (years)</td><td colspan="1" rowspan="1" align="center" valign="top">48 &#x000b1; 7</td><td colspan="1" rowspan="1" align="center" valign="top">46 &#x000b1; 8</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.39</td><td colspan="1" rowspan="1" align="center" valign="top">48 &#x000b1; 8</td><td colspan="1" rowspan="1" align="center" valign="top">53 &#x000b1; 8</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.11</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Systolic blood pressure (mmHg)</td><td colspan="1" rowspan="1" align="center" valign="top">124 &#x000b1; 17</td><td colspan="1" rowspan="1" align="center" valign="top">127 &#x000b1; 12</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.52</td><td colspan="1" rowspan="1" align="center" valign="top">135 &#x000b1; 16<xref ref-type="table-fn" rid="t1fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">139 &#x000b1; 22</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.60</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Diastolic blood pressure (mmHg)</td><td colspan="1" rowspan="1" align="center" valign="top">72 &#x000b1; 11</td><td colspan="1" rowspan="1" align="center" valign="top">76 &#x000b1; 12</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.28</td><td colspan="1" rowspan="1" align="center" valign="top">80 &#x000b1; 14<xref ref-type="table-fn" rid="t1fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">79 &#x000b1; 10</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.88</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Anthropometry</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;BMI (kg/m<sup>2</sup>)</td><td colspan="1" rowspan="1" align="center" valign="top">34.3 &#x000b1; 4.4</td><td colspan="1" rowspan="1" align="center" valign="top">36.4 &#x000b1; 3.8</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.09</td><td colspan="1" rowspan="1" align="center" valign="top">33.4 &#x000b1; 5.1</td><td colspan="1" rowspan="1" align="center" valign="top">34.7 &#x000b1; 3.9</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.47</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Waist circumference (cm)</td><td colspan="1" rowspan="1" align="center" valign="top">103 &#x000b1; 9.0</td><td colspan="1" rowspan="1" align="center" valign="top">111 &#x000b1; 9</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.002</td><td colspan="1" rowspan="1" align="center" valign="top">114 &#x000b1; 13</td><td colspan="1" rowspan="1" align="center" valign="top">116 &#x000b1; 10</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.57</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;WHR</td><td colspan="1" rowspan="1" align="center" valign="top">0.87 &#x000b1; 0.05</td><td colspan="1" rowspan="1" align="center" valign="top">0.90 &#x000b1; 0.05</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.05</td><td colspan="1" rowspan="1" align="center" valign="top">0.98 &#x000b1; 0.07<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">0.99 &#x000b1; 0.04<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.46</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Serum biochemistry</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Fasting glucose (mmol/l)</td><td colspan="1" rowspan="1" align="center" valign="top">4.6 &#x000b1; 0.6</td><td colspan="1" rowspan="1" align="center" valign="top">5.0 &#x000b1; 0.4</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td><td colspan="1" rowspan="1" align="center" valign="top">4.8 &#x000b1; 0.5</td><td colspan="1" rowspan="1" align="center" valign="top">5.4 &#x000b1; 0.6<xref ref-type="table-fn" rid="t1fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.009</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;2-h glucose (mmol/l)</td><td colspan="1" rowspan="1" align="center" valign="top">6.0 &#x000b1; 1.0</td><td colspan="1" rowspan="1" align="center" valign="top">8.8 &#x000b1; 0.9</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x0003c;0.001</td><td colspan="1" rowspan="1" align="center" valign="top">5.4 &#x000b1; 1.4<xref ref-type="table-fn" rid="t1fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">9.2 &#x000b1; 1.5</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x0003c;0.001</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Fasting insulin (IU/l)</td><td colspan="1" rowspan="1" align="center" valign="top">10.0 &#x000b1; 7.2</td><td colspan="1" rowspan="1" align="center" valign="top">12.3 &#x000b1; 6.3</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.27</td><td colspan="1" rowspan="1" align="center" valign="top">8.7 &#x000b1; 3.9</td><td colspan="1" rowspan="1" align="center" valign="top">12.1 &#x000b1; 7.2</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.12</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;2-h insulin (IU/l)</td><td colspan="1" rowspan="1" align="center" valign="top">97.8 &#x000b1; 66.0</td><td colspan="1" rowspan="1" align="center" valign="top">128 &#x000b1; 58.0</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.12</td><td colspan="1" rowspan="1" align="center" valign="top">52.0 &#x000b1; 40.9<xref ref-type="table-fn" rid="t1fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">97.6 &#x000b1; 56.7</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;AUC insulin (IU &#x000b7; l<sup>&#x02212;1</sup> &#x000b7; h<sup>&#x02212;1</sup>)</td><td colspan="1" rowspan="1" align="center" valign="top">167.6 &#x000b1; 91.8</td><td colspan="1" rowspan="1" align="center" valign="top">173.7 &#x000b1; 67.6</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.81</td><td colspan="1" rowspan="1" align="center" valign="top">162.6 &#x000b1; 75.5</td><td colspan="1" rowspan="1" align="center" valign="top">158.9 &#x000b1; 107.6</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.92</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;A1C (&#x00025;)</td><td colspan="1" rowspan="1" align="center" valign="top">5.4 &#x000b1; 0.5</td><td colspan="1" rowspan="1" align="center" valign="top">5.7 &#x000b1; 0.4</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.08</td><td colspan="1" rowspan="1" align="center" valign="top">5.3 &#x000b1; 0.3</td><td colspan="1" rowspan="1" align="center" valign="top">5.9 &#x000b1; 0.9</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.03</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;HOMA-&#x00025;B</td><td colspan="1" rowspan="1" align="center" valign="top">141.6 &#x000b1; 52.2</td><td colspan="1" rowspan="1" align="center" valign="top">143.5 &#x000b1; 52.6</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.90</td><td colspan="1" rowspan="1" align="center" valign="top">119.2 &#x000b1; 32.6</td><td colspan="1" rowspan="1" align="center" valign="top">118.9 &#x000b1; 44.9</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.98</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;HOMA-&#x00025;S</td><td colspan="1" rowspan="1" align="center" valign="top">104.6 &#x000b1; 71.5</td><td colspan="1" rowspan="1" align="center" valign="top">78.2 &#x000b1; 61.8</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.20</td><td colspan="1" rowspan="1" align="center" valign="top">101.5 &#x000b1; 60.1</td><td colspan="1" rowspan="1" align="center" valign="top">75.7 &#x000b1; 42.1</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.20</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;HOMA-R</td><td colspan="1" rowspan="1" align="center" valign="top">1.5 &#x000b1; 1.0</td><td colspan="1" rowspan="1" align="center" valign="top">1.8 &#x000b1; 0.9</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.25</td><td colspan="1" rowspan="1" align="center" valign="top">1.3 &#x000b1; 0.6</td><td colspan="1" rowspan="1" align="center" valign="top">1.3 &#x000b1; 1.1</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.10</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total cholesterol (mmol/l)</td><td colspan="1" rowspan="1" align="center" valign="top">5.0 &#x000b1; 1.0</td><td colspan="1" rowspan="1" align="center" valign="top">5.3 &#x000b1; 1.0</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.29</td><td colspan="1" rowspan="1" align="center" valign="top">5.3 &#x000b1; 0.9</td><td colspan="1" rowspan="1" align="center" valign="top">5.0 &#x000b1; 0.7</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.48</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Triglycerides (mmol/l)</td><td colspan="1" rowspan="1" align="center" valign="top">1.3 &#x000b1; 0.6</td><td colspan="1" rowspan="1" align="center" valign="top">1.6 &#x000b1; 0.6</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.11</td><td colspan="1" rowspan="1" align="center" valign="top">2.0 &#x000b1; 1.8<xref ref-type="table-fn" rid="t1fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">1.7 &#x000b1; 0.8</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.57</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Cortisol (nmol/l)</td><td colspan="1" rowspan="1" align="center" valign="top">216 &#x000b1; 103</td><td colspan="1" rowspan="1" align="center" valign="top">204 &#x000b1; 102</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.70</td><td colspan="1" rowspan="1" align="center" valign="top">320 &#x000b1; 163<xref ref-type="table-fn" rid="t1fn3">&#x02021;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">239 &#x000b1; 80</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.12</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Cortisone (nmol/l)</td><td colspan="1" rowspan="1" align="center" valign="top">64 &#x000b1; 26</td><td colspan="1" rowspan="1" align="center" valign="top">55 &#x000b1; 22</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.30</td><td colspan="1" rowspan="1" align="center" valign="top">66 &#x000b1; 20</td><td colspan="1" rowspan="1" align="center" valign="top">73 &#x000b1; 19<xref ref-type="table-fn" rid="t1fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.42</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Body composition (DEXA)</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Trunk fat mass (kg)</td><td colspan="1" rowspan="1" align="center" valign="top">19.5 &#x000b1; 5.0</td><td colspan="1" rowspan="1" align="center" valign="top">21.7 &#x000b1; 4.3</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.14</td><td colspan="1" rowspan="1" align="center" valign="top">16.8 &#x000b1; 4.7</td><td colspan="1" rowspan="1" align="center" valign="top">19.2 &#x000b1; 4.8</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.22</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Trunk fat-free mass (kg)</td><td colspan="1" rowspan="1" align="center" valign="top">25.2 &#x000b1; 3.2</td><td colspan="1" rowspan="1" align="center" valign="top">26.1 &#x000b1; 4.3</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.39</td><td colspan="1" rowspan="1" align="center" valign="top">34.6 &#x000b1; 4.4<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">35.7 &#x000b1; 3.9<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.50</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total fat mass (kg)</td><td colspan="1" rowspan="1" align="center" valign="top">38.8 &#x000b1; 9.2</td><td colspan="1" rowspan="1" align="center" valign="top">41.7 &#x000b1; 9.3</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.30</td><td colspan="1" rowspan="1" align="center" valign="top">29.9 &#x000b1; 7.7<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">34.4 &#x000b1; 8.9<xref ref-type="table-fn" rid="t1fn3">&#x02021;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.17</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total fat-free mass (kg)</td><td colspan="1" rowspan="1" align="center" valign="top">48.6 &#x000b1; 5.7</td><td colspan="1" rowspan="1" align="center" valign="top">50.2 &#x000b1; 8.4</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.39</td><td colspan="1" rowspan="1" align="center" valign="top">66.9 &#x000b1; 8.1<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">68.7 &#x000b1; 7.3<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.54</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total &#x00025; fat</td><td colspan="1" rowspan="1" align="center" valign="top">43.0 &#x000b1; 4.3</td><td colspan="1" rowspan="1" align="center" valign="top">44.1 &#x000b1; 5.0</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.41</td><td colspan="1" rowspan="1" align="center" valign="top">29.7 &#x000b1; 4.2<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">32.2 &#x000b1; 5.6<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.21</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Trunk fat&#x02013;to&#x02013;limb fat ratio</td><td colspan="1" rowspan="1" align="center" valign="top">1.1 &#x000b1; 0.2</td><td colspan="1" rowspan="1" align="center" valign="top">1.2 &#x000b1; 0.3</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.09</td><td colspan="1" rowspan="1" align="center" valign="top">1.4 &#x000b1; 0.14<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">1.4 &#x000b1; 0.23</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.71</td></tr></tbody></table><table-wrap-foot><fn><p>Data are means &#x000b1; SD unless otherwise indicated.</p></fn><fn id="t1fn1"><label>&#x0002a;</label><p><italic>P</italic> &#x0003c; 0.05;</p></fn><fn id="t1fn2"><label>&#x02020;</label><p><italic>P</italic> &#x0003c; 0.0001;</p></fn><fn id="t1fn3"><label>&#x02021;</label><p><italic>P</italic> &#x0003c; 0.01 vs. women.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="t2"><label>TABLE 2</label><caption><p>Urinary corticosteroid metabolite analysis performed by GC/MS on 24-h urine samples from 73 obese volunteers divided by sex and glucose tolerance</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="3" rowspan="1" align="center" valign="bottom">Women <hr/></th><th colspan="3" rowspan="1" align="center" valign="bottom">Men <hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="1" rowspan="1" align="center" valign="bottom">Normal</th><th colspan="1" rowspan="1" align="center" valign="bottom">IGT</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th><th colspan="1" rowspan="1" align="center" valign="bottom">Normal</th><th colspan="1" rowspan="1" align="center" valign="bottom">IGT</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>n</italic></td><td colspan="1" rowspan="1" align="center" valign="top">35</td><td colspan="1" rowspan="1" align="center" valign="top">11</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top">14</td><td colspan="1" rowspan="1" align="center" valign="top">12</td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Corticosteroid metabolite production (&#x003bc;g/24h)</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total glucocorticoid metabolites</td><td colspan="1" rowspan="1" align="center" valign="top">7,453 &#x000b1; 2,693</td><td colspan="1" rowspan="1" align="center" valign="top">9,964 &#x000b1; 4,741</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.03</td><td colspan="1" rowspan="1" align="center" valign="top">13,743 &#x000b1; 3,229<xref ref-type="table-fn" rid="t2fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">16,871 &#x000b1; 7,619<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.17</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total cortisol metabolites (Fm)</td><td colspan="1" rowspan="1" align="center" valign="top">3,088 &#x000b1; 1,230</td><td colspan="1" rowspan="1" align="center" valign="top">3,933 &#x000b1; 2,103</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.10</td><td colspan="1" rowspan="1" align="center" valign="top">5,481 &#x000b1; 1,484<xref ref-type="table-fn" rid="t2fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">6,679 &#x000b1; 2,911<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.19</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total cortisone metabolites (Em)</td><td colspan="1" rowspan="1" align="center" valign="top">4,364 &#x000b1; 1,697</td><td colspan="1" rowspan="1" align="center" valign="top">6,031 &#x000b1; 2,702</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td><td colspan="1" rowspan="1" align="center" valign="top">8,263 &#x000b1; 1,971<xref ref-type="table-fn" rid="t2fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">10,192 &#x000b1; 4,833<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.18</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;THF</td><td colspan="1" rowspan="1" align="center" valign="top">1,440 &#x000b1; 958</td><td colspan="1" rowspan="1" align="center" valign="top">1,756 &#x000b1; 910</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.32</td><td colspan="1" rowspan="1" align="center" valign="top">2,387 &#x000b1; 481<xref ref-type="table-fn" rid="t2fn3">&#x02021;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">2,757 &#x000b1; 1,346<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.34</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;5&#x003b1;THF</td><td colspan="1" rowspan="1" align="center" valign="top">1,087 &#x000b1; 597</td><td colspan="1" rowspan="1" align="center" valign="top">1,382 &#x000b1; 929</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.21</td><td colspan="1" rowspan="1" align="center" valign="top">1,997 &#x000b1; 1,176<xref ref-type="table-fn" rid="t2fn3">&#x02021;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">2,553 &#x000b1; 1,395<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.27</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;THE</td><td colspan="1" rowspan="1" align="center" valign="top">2,777 &#x000b1; 1,670</td><td colspan="1" rowspan="1" align="center" valign="top">3,677 &#x000b1; 1,720</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.12</td><td colspan="1" rowspan="1" align="center" valign="top">5,183 &#x000b1; 1,562<xref ref-type="table-fn" rid="t2fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">6,274 &#x000b1; 3,421<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.29</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;UFF</td><td colspan="1" rowspan="1" align="center" valign="top">56 &#x000b1; 76</td><td colspan="1" rowspan="1" align="center" valign="top">48 &#x000b1; 22</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.74</td><td colspan="1" rowspan="1" align="center" valign="top">80 &#x000b1; 29</td><td colspan="1" rowspan="1" align="center" valign="top">98 &#x000b1; 40<xref ref-type="table-fn" rid="t2fn3">&#x02021;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.20</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;UFE</td><td colspan="1" rowspan="1" align="center" valign="top">79 &#x000b1; 37</td><td colspan="1" rowspan="1" align="center" valign="top">83 &#x000b1; 35</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.72</td><td colspan="1" rowspan="1" align="center" valign="top">127 &#x000b1; 43<xref ref-type="table-fn" rid="t2fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">152 &#x000b1; 71<xref ref-type="table-fn" rid="t2fn3">&#x02021;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.27</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;&#x003b1;-cortol</td><td colspan="1" rowspan="1" align="center" valign="top">303 &#x000b1; 155</td><td colspan="1" rowspan="1" align="center" valign="top">351 &#x000b1; 179</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.37</td><td colspan="1" rowspan="1" align="center" valign="top">415 &#x000b1; 112<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">535 &#x000b1; 185<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.05</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;&#x003b2;-Cortol</td><td colspan="1" rowspan="1" align="center" valign="top">379 &#x000b1; 183</td><td colspan="1" rowspan="1" align="center" valign="top">395 &#x000b1; 157</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.79</td><td colspan="1" rowspan="1" align="center" valign="top">603 &#x000b1; 232<xref ref-type="table-fn" rid="t2fn3">&#x02021;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">737 &#x000b1; 366<xref ref-type="table-fn" rid="t2fn3">&#x02021;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.26</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;&#x003b1;-Cortolone</td><td colspan="1" rowspan="1" align="center" valign="top">1,243 &#x000b1; 516</td><td colspan="1" rowspan="1" align="center" valign="top">1,612 &#x000b1; 729</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.06</td><td colspan="1" rowspan="1" align="center" valign="top">1,908 &#x000b1; 534<xref ref-type="table-fn" rid="t2fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">2,499 &#x000b1; 830<xref ref-type="table-fn" rid="t2fn3">&#x02021;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.04</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;&#x003b2;-Cortolone</td><td colspan="1" rowspan="1" align="center" valign="top">524 &#x000b1; 278</td><td colspan="1" rowspan="1" align="center" valign="top">659 &#x000b1; 328</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.17</td><td colspan="1" rowspan="1" align="center" valign="top">1,046 &#x000b1; 280<xref ref-type="table-fn" rid="t2fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">1,267 &#x000b1; 697<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.28</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Androsterone</td><td colspan="1" rowspan="1" align="center" valign="top">1,054 &#x000b1; 746</td><td colspan="1" rowspan="1" align="center" valign="top">1,371 &#x000b1; 1,009</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.25</td><td colspan="1" rowspan="1" align="center" valign="top">2,246 &#x000b1; 900<xref ref-type="table-fn" rid="t2fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">2,602 &#x000b1; 2,169</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.58</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Etiocholanolone</td><td colspan="1" rowspan="1" align="center" valign="top">1,020 &#x000b1; 742</td><td colspan="1" rowspan="1" align="center" valign="top">1,192 &#x000b1; 737</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.49</td><td colspan="1" rowspan="1" align="center" valign="top">2,075 &#x000b1; 1,081<xref ref-type="table-fn" rid="t2fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">2,296 &#x000b1; 1,999</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.72</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Corticosteroid metabolite ratios</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;UFF-to-UFE</td><td colspan="1" rowspan="1" align="center" valign="top">0.64 &#x000b1; 0.53</td><td colspan="1" rowspan="1" align="center" valign="top">0.63 &#x000b1; 0.25</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.93</td><td colspan="1" rowspan="1" align="center" valign="top">0.63 &#x000b1; 0.11</td><td colspan="1" rowspan="1" align="center" valign="top">0.66 &#x000b1; 0.13</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.48</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;(THF &#x0002b; 5&#x003b1;THF)-to-THF</td><td colspan="1" rowspan="1" align="center" valign="top">0.98 &#x000b1; 0.39</td><td colspan="1" rowspan="1" align="center" valign="top">0.84 &#x000b1; 0.18</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.24</td><td colspan="1" rowspan="1" align="center" valign="top">0.86 &#x000b1; 0.0.16</td><td colspan="1" rowspan="1" align="center" valign="top">0.87 &#x000b1; 0.19</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.88</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Cortols-to-cortolones</td><td colspan="1" rowspan="1" align="center" valign="top">0.39 &#x000b1; 0.1</td><td colspan="1" rowspan="1" align="center" valign="top">0.33 &#x000b1; 0.05</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.06</td><td colspan="1" rowspan="1" align="center" valign="top">0.35 &#x000b1; 0.07</td><td colspan="1" rowspan="1" align="center" valign="top">0.34 &#x000b1; 0.09</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.94</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;(11OH-and &#x0002b; 11OH-etio)&#x02013;to&#x02013;11oxo-etio</td><td colspan="1" rowspan="1" align="center" valign="top">3.17 &#x000b1; 2.0</td><td colspan="1" rowspan="1" align="center" valign="top">3.38 &#x000b1; 1.87</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.76</td><td colspan="1" rowspan="1" align="center" valign="top">3.23 &#x000b1; 1.18</td><td colspan="1" rowspan="1" align="center" valign="top">2.83 &#x000b1; 1.29</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.41</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Fm-to-Em</td><td colspan="1" rowspan="1" align="center" valign="top">0.73 &#x000b1; 0.23</td><td colspan="1" rowspan="1" align="center" valign="top">0.64 &#x000b1; 0.12</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.21</td><td colspan="1" rowspan="1" align="center" valign="top">0.67 &#x000b1; 0.12</td><td colspan="1" rowspan="1" align="center" valign="top">0.66 &#x000b1; 0.12</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.92</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Androsterone-to-etiocholanolone</td><td colspan="1" rowspan="1" align="center" valign="top">1.15 &#x000b1; 0.55</td><td colspan="1" rowspan="1" align="center" valign="top">1.14 &#x000b1; 0.43</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.99</td><td colspan="1" rowspan="1" align="center" valign="top">1.27 &#x000b1; 0.58</td><td colspan="1" rowspan="1" align="center" valign="top">1.24 &#x000b1; 0.47</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.89</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;5&#x003b1;THF-to-THF</td><td colspan="1" rowspan="1" align="center" valign="top">0.84 &#x000b1; 0.41</td><td colspan="1" rowspan="1" align="center" valign="top">0.76 &#x000b1; 0.26</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.53</td><td colspan="1" rowspan="1" align="center" valign="top">0.84 &#x000b1; 0.45</td><td colspan="1" rowspan="1" align="center" valign="top">0.97 &#x000b1; 0.41</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.47</td></tr></tbody></table><table-wrap-foot><fn><p>Data are means &#x000b1; SD. UFF, urinary free cortisol; UFE, urinary free cortisone; 11OH-and, 11hydroxyandrosterone; 11OH-etio, 11hydroxyetiocholanolone; 11oxo-etio, 11oxo-etiocholanolone; Fm, cortisol &#x0002b; THF &#x0002b; 5&#x003b1;THF &#x0002b; &#x003b1;-cortol &#x0002b; &#x003b2;-cortol; Em, cortisone &#x0002b; THE &#x0002b; &#x003b1;-cortolone &#x0002b; &#x003b2;-cortolone.</p></fn><fn id="t2fn1"><label>&#x0002a;</label><p><italic>P</italic> &#x0003c; 0.0001;</p></fn><fn id="t2fn2"><label>&#x02020;</label><p><italic>P</italic> &#x0003c; 0.05;</p></fn><fn id="t2fn3"><label>&#x02021;</label><p><italic>P</italic> &#x0003c; 0.01 vs. women.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="t3"><label>TABLE 3</label><caption><p>Correlation of metabolic parameters with 5&#x003b1;-reductase activity as assessed by the urinary 5&#x003b1;THF-to-THF and androsterone-to-etiocholanolone ratios analyzed by GC/MS</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="4" rowspan="1" align="center" valign="bottom">Women (<italic>n</italic> &#x0003d; 49) <hr/></th><th colspan="4" rowspan="1" align="center" valign="bottom">Men (<italic>n</italic> &#x0003d; 30) <hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="2" rowspan="1" align="center" valign="bottom">Androsterone-to-etiocholanolone ratio <hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom">5&#x003b1;THF-to-THF ratio <hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom">Androsterone-to-etiocholanolone ratio <hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom">5&#x003b1;THF-to-THF ratio <hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="1" rowspan="1" align="center" valign="bottom">Correlation coefficient (<italic>R</italic>)</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th><th colspan="1" rowspan="1" align="center" valign="bottom">Correlation coefficient (<italic>R</italic>)</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th><th colspan="1" rowspan="1" align="center" valign="bottom">Correlation coefficient (<italic>R</italic>)</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th><th colspan="1" rowspan="1" align="center" valign="bottom">Correlation coefficient (<italic>R</italic>)</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top">Insulin sensitivity and glucose tolerance</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Fasting glucose</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.082</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.58</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.065</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.66</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.26</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.17</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.22</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.26</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;2-h glucose</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.14</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.35</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.13</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.37</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.13</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.51</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.81</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.67</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Fasting insulin</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.33</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.022</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.27</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.07</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.53</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.003</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.50</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.006</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;2-h insulin</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.51</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0002</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.51</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0002</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.14</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.48</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.35</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.06</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;AUC insulin</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.38</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.007</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.40</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.004</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.31</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.10</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.46</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.01</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;A1C</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.11</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.47</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.09</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.58</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.39</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.04</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.14</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.47</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;HOMA-&#x00025;B</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.26</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.07</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.22</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.13</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.47</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.01</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.55</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.003</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;HOMA-&#x00025;S</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.27</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.06</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.23</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.11</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.43</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.53</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.003</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;HOMA-R</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.33</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.26</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.07</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.52</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.004</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.49</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.008</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Anthropometry</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;BMI</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.14</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.35</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.87</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.28</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.13</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.32</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.08</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Waist circumference</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.15</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.33</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.90</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.03</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.89</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.14</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.46</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;WHR</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.09</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.56</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.16</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.27</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.09</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.62</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.05</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.81</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Body composition (DEXA)</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Trunk fat mass</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.06</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.67</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.04</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.78</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.44</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.46</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.01</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Trunk fat-free mass</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.11</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.45</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.006</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.97</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.41</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.03</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.41</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.03</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total fat mass</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.90</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.10</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.51</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.36</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.06</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.38</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.04</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total fat-free mass</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.09</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.56</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.87</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.493</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.008</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.43</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total &#x00025; fat</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.89</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.07</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.62</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.18</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.37</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.24</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.23</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Trunk fat&#x02013;to&#x02013;limb fat ratio</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.10</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.51</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.10</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.52</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.27</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.17</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.26</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.18</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t4"><label>TABLE 4</label><caption><p>Correlation of metabolic parameters with glucocorticoid secretion rate and 11&#x003b2;-HSD1 activity (as measured by the urinary 5&#x003b1;THF &#x0002b; THF&#x02013;to&#x02013;THE ratio) analyzed by GC/MS</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="4" rowspan="1" align="center" valign="bottom">Women (<italic>n</italic> &#x0003d; 49) <hr/></th><th colspan="4" rowspan="1" align="center" valign="bottom">Men (<italic>n</italic> &#x0003d; 30) <hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="2" rowspan="1" align="center" valign="bottom">Total glucocorticoid secretion rate <hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom">(5&#x003b1;THF &#x0002b; THF)-to-THF ratio <hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom">Total glucocorticoid secretion rate <hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom">(5&#x003b1;THF &#x0002b; THF)-to-THF ratio <hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="1" rowspan="1" align="center" valign="bottom">Correlation coefficient (<italic>R</italic>)</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th><th colspan="1" rowspan="1" align="center" valign="bottom">Correlation coefficient (<italic>R</italic>)</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th><th colspan="1" rowspan="1" align="center" valign="bottom">Correlation coefficient (<italic>R</italic>)</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th><th colspan="1" rowspan="1" align="center" valign="bottom">Correlation coefficient (<italic>R</italic>)</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top">Insulin sensitivity and glucose tolerance</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Fasting glucose</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.06</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.70</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.05</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.74</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.07</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.73</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.28</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.14</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;2-h glucose</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.22</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.15</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.01</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.97</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.10</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.59</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.34</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.07</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Fasting insulin</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.25</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.09</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.01</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.95</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.04</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.83</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.37</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.05</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;2-h insulin</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.34</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.07</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.64</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.12</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.53</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.03</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.88</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;AUC insulin</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.17</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.25</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.08</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.61</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.07</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.70</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.01</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.96</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;A1C</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.00</td><td colspan="1" rowspan="1" align="char" char="." valign="top">1.0</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.12</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.47</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.16</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.43</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.45</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.17</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;HOMA-&#x00025;B</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.19</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.20</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.04</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.78</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.08</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.67</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.22</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.26</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;HOMA-&#x00025;S</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.18</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.24</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.10</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.49</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.16</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.42</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.35</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.06</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;HOMA-R</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.25</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.09</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.00</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.98</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.04</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.85</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.38</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.04</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Anthropometry</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;BMI</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.32</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.03</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.13</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.38</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.21</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.28</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.14</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.46</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Waist circumference</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.32</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.03</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.03</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.87</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.07</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.73</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.28</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.14</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;WHR</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.04</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.70</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.18</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.23</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.05</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.78</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.92</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Body composition (DEXA)</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Trunk fat mass</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.44</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.002</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.05</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.76</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.22</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.27</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.35</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.07</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Trunk fat-free mass</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.44</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.002</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.06</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.68</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.28</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.15</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.33</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.09</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total fat mass</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.41</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.006</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.14</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.37</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.25</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.20</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.25</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.20</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total fat-free mass</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.38</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.01</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.06</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.67</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.12</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.56</td><td colspan="1" rowspan="1" align="char" char="." valign="top">031</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.11</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Total &#x00025; fat</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.19</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.20</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.21</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.16</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.23</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.23</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.14</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.49</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Trunk fat&#x02013;to&#x02013;limb fat ratio</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.19</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.22</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.23</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.13</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;0.005</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.98</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.31</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.11</td></tr></tbody></table></table-wrap></floats-wrap></article> 